RESUMO
OBJECTIVE: To investigate the DNMT3B (C46359T) polymorphism and immunoexpression of DNMT3b and DNMT1 in oral lichen planus (OLP) compared to a control group. METHODS: We aimed to investigate the DNMT3B (C46359T) polymorphism and immunoexpression of DNMT3b and DNMT1 in OLP (n = 32), comparing it with oral mucosa (control; n = 24). The DNMT3B (C46359T) polymorphism was analyzed using the RFLP-PCR and DNMT1, and DNMT3a proteins were identified using immunohistochemistry. We also compared the DNMT3B expression in OLP and oral inflammatory fibrous hyperplasia (OIFH), another oral inflammatory disease. Differences between the groups were determined by specific statistical analyses. RESULTS: The CT genotype of DNMT3B was associated with OLP development (p = 0.012). Increased expression of DNMT3B and DNMT1 was observed in OLP compared to the control group (p = 0.014 and p = 0.001, respectively). A significant increase in DNMT3B protein levels was observed in the genotype CT in DNMT3B (C46359T) polymorphisms (p = 0.045). No DNMT3B expression differences between OLP and OIFH were observed. CONCLUSIONS: Our data show that the DNMT3B (C46359T) polymorphism is associated with OLP development. Furthermore, increased expression of the enzyme DNMT3B, an epigenetic-associated protein, is present in OLP.
Assuntos
DNA (Citosina-5-)-Metiltransferases/genética , DNA (Citosina-5-)-Metiltransferases/metabolismo , Líquen Plano Bucal/genética , Polimorfismo de Nucleotídeo Único , Proteínas Repressoras/metabolismo , Adolescente , Adulto , Idoso , DNA (Citosina-5-)-Metiltransferases/imunologia , DNA Metiltransferase 3A , Feminino , Frequência do Gene/genética , Humanos , Imuno-Histoquímica , Líquen Plano Bucal/metabolismo , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/metabolismo , Proteínas Repressoras/imunologia , Adulto Jovem , DNA Metiltransferase 3BRESUMO
OBJECTIVES: This study aimed to examine the association of CD57+ T cells and MVD withclinical parameters and prognosis of HNSCC. MATERIAL AND METHOD: In a restrospectiveanalysis, 43 cases of primary HNSCC have been studied. We also analysed CD57 and CD31counting. T and N parameters was analized by Binary logistic regression analysis. Survival wasanalysed by Cox regression analysis. RESULTS: CD31 was not associated with anyclinicopathological parameters. CD57 immunoexpression was associated with locorregionalpresence. Cox regression test showed correlation of worse survival with locorregional metastasispresence. For binary logistic parameter, WHO Grade parameter was associated with smaller tumorsize and absent metastasis CD57+ T cells count was relationed with worse survival.CONCLUSION: There was no association between MVD and clinicopathological parameters.Locorregional metastasis presenting high CD57 positivity. No association was found betweenCD57 and the other clinicopathological parameters. Multivariate analysis showed that individualspresenting locorregional metastasis were associated with poor survival. CD57 count and WHOgrade were associated with larger tumor size.
OBJETIVO: Estudou-se a associação de células CD57+T e densidade microvascular comparâmetros clínicos e prognóstico do carcinoma de células escamosas de cabeça e pescoço(CCECP). MATERIAL E MÉTODO: Em análise retrospectiva, 43 casos de CCEP foramestudados. Analisamos também a contagem de CD57 e CD32. Os parâmetros T e N foramanalisados pela análise da regressão logística binária. A sobrevivência foi submetida a anális deregressão de Cox. RESULTADOS: CD31 não foi associada com nenhum parâmetroclinicopatológico. A imunoexpressão do CD57 associou-se com presença locorregional. O testede regressão de Cox demonstrou correlação entre pior sobrevivência com presença locorregionalde metástase. Para o parâmetro de logística binária, o parâmetro da OMS foi associado comtumores menores e ausência de metástases. A contagem das células CD57+ foi relacionada coma pior sobrevivência. CONCLUSÃO: Não houve associação entre microdensidade vascular eparâmetros clínico-patológicos. Metástases locorregionais apresentaram alta positividade paraCD57. Não foi encontrada associação entre CD57 e outros parâmetros clínico-patológicos. Análisemultivariada demonstrou que indivíduos apresentando metástases locorregionais apresentarampobre sobrevida. Contagem de CD57 e grau da OMS foram associados com tumores maiores.
